364 related articles for article (PubMed ID: 26279205)
21. Resolving the polygenic aetiology of a late onset combined immune deficiency caused by NFKB1 haploinsufficiency and modified by PIK3R1 and TNFRSF13B variants.
Hargreaves CE; Dhalla F; Patel AM; de Oteyza ACG; Bateman E; Miller J; Anzilotti C; Ayers L; Grimbacher B; Patel SY
Clin Immunol; 2022 Jan; 234():108910. PubMed ID: 34922003
[TBL] [Abstract][Full Text] [Related]
22. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology.
Beinke S; Ley SC
Biochem J; 2004 Sep; 382(Pt 2):393-409. PubMed ID: 15214841
[TBL] [Abstract][Full Text] [Related]
23. Lack of NF-kappaB1 (p105/p50) attenuates unloading-induced downregulation of PPARalpha and PPARalpha-regulated gene expression in rodent heart.
Razeghi P; Wang ME; Youker KA; Golfman L; Stepkowski S; Taegtmeyer H
Cardiovasc Res; 2007 Apr; 74(1):133-9. PubMed ID: 17276423
[TBL] [Abstract][Full Text] [Related]
24. The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation-independent manner.
Moorthy AK; Savinova OV; Ho JQ; Wang VY; Vu D; Ghosh G
EMBO J; 2006 May; 25(9):1945-56. PubMed ID: 16619030
[TBL] [Abstract][Full Text] [Related]
25. Defining the Role of Nuclear Factor (NF)-κB p105 Subunit in Human Macrophage by Transcriptomic Analysis of
Somma D; Kok FO; Kerrigan D; Wells CA; Carmody RJ
Front Immunol; 2021; 12():669906. PubMed ID: 34721373
[TBL] [Abstract][Full Text] [Related]
26. Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressor.
Voce DJ; Schmitt AM; Uppal A; McNerney ME; Bernal GM; Cahill KE; Wahlstrom JS; Nassiri A; Yu X; Crawley CD; White KP; Onel K; Weichselbaum RR; Yamini B
Oncogene; 2015 May; 34(21):2807-13. PubMed ID: 25043302
[TBL] [Abstract][Full Text] [Related]
27. TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.
Belich MP; Salmerón A; Johnston LH; Ley SC
Nature; 1999 Jan; 397(6717):363-8. PubMed ID: 9950430
[TBL] [Abstract][Full Text] [Related]
28. IKK-induced NF-κB1 p105 proteolysis is critical for B cell antibody responses to T cell-dependent antigen.
Jacque E; Schweighoffer E; Visekruna A; Papoutsopoulou S; Janzen J; Zillwood R; Tarlinton DM; Tybulewicz VL; Ley SC
J Exp Med; 2014 Sep; 211(10):2085-101. PubMed ID: 25225457
[TBL] [Abstract][Full Text] [Related]
29. Mutation in IRF2BP2 is responsible for a familial form of common variable immunodeficiency disorder.
Keller MD; Pandey R; Li D; Glessner J; Tian L; Henrickson SE; Chinn IK; Monaco-Shawver L; Heimall J; Hou C; Otieno FG; Jyonouchi S; Calabrese L; van Montfrans J; Orange JS; Hakonarson H
J Allergy Clin Immunol; 2016 Aug; 138(2):544-550.e4. PubMed ID: 27016798
[TBL] [Abstract][Full Text] [Related]
30. Early and late B-cell developmental impairment in nuclear factor kappa B, subunit 1-mutated common variable immunodeficiency disease.
Lougaris V; Moratto D; Baronio M; Tampella G; van der Meer JWM; Badolato R; Fliegauf M; Plebani A
J Allergy Clin Immunol; 2017 Jan; 139(1):349-352.e1. PubMed ID: 27555455
[No Abstract] [Full Text] [Related]
31. NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function.
Sun F; Qu Z; Xiao Y; Zhou J; Burns TF; Stabile LP; Siegfried JM; Xiao G
Oncogene; 2016 May; 35(18):2299-310. PubMed ID: 26300007
[TBL] [Abstract][Full Text] [Related]
32. Nuclear factor-kappaB1: regulation and function.
Pereira SG; Oakley F
Int J Biochem Cell Biol; 2008; 40(8):1425-30. PubMed ID: 17693123
[TBL] [Abstract][Full Text] [Related]
33. Combined immunodeficiency caused by a novel homozygous NFKB1 mutation.
Mandola AB; Sharfe N; Nagdi Z; Dadi H; Vong L; Merico D; Ngan B; Reid B; Roifman CM
J Allergy Clin Immunol; 2021 Feb; 147(2):727-733.e2. PubMed ID: 32980423
[TBL] [Abstract][Full Text] [Related]
34. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
Cogswell PC; Scheinman RI; Baldwin AS
J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
[TBL] [Abstract][Full Text] [Related]
35. Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes.
Kaustio M; Haapaniemi E; Göös H; Hautala T; Park G; Syrjänen J; Einarsdottir E; Sahu B; Kilpinen S; Rounioja S; Fogarty CL; Glumoff V; Kulmala P; Katayama S; Tamene F; Trotta L; Morgunova E; Krjutškov K; Nurmi K; Eklund K; Lagerstedt A; Helminen M; Martelius T; Mustjoki S; Taipale J; Saarela J; Kere J; Varjosalo M; Seppänen M
J Allergy Clin Immunol; 2017 Sep; 140(3):782-796. PubMed ID: 28115215
[TBL] [Abstract][Full Text] [Related]
36. Disturbed canonical nuclear factor of κ light chain signaling in B cells of patients with common variable immunodeficiency.
Keller B; Cseresnyes Z; Stumpf I; Wehr C; Fliegauf M; Bulashevska A; Usadel S; Grimbacher B; Rizzi M; Eibel H; Niesner R; Warnatz K
J Allergy Clin Immunol; 2017 Jan; 139(1):220-231.e8. PubMed ID: 27461466
[TBL] [Abstract][Full Text] [Related]
37. Th1-skewed profile and excessive production of proinflammatory cytokines in a NFKB1-deficient patient with CVID and severe gastrointestinal manifestations.
Dieli-Crimi R; Martínez-Gallo M; Franco-Jarava C; Antolin M; Blasco L; Paramonov I; Semidey ME; Álvarez Fernández A; Molero X; Velásquez J; Martín-Nalda A; Pujol-Borrell R; Colobran R
Clin Immunol; 2018 Oct; 195():49-58. PubMed ID: 30063981
[TBL] [Abstract][Full Text] [Related]
38. Characterization of ES cells deficient for the p105 precursor (NF-kappa B1): role of p50 NLS.
Ishikawa H; Ryseck RP; Bravo R
Oncogene; 1996 Jul; 13(2):255-63. PubMed ID: 8710364
[TBL] [Abstract][Full Text] [Related]
39. NFKB1: a suppressor of inflammation, ageing and cancer.
Cartwright T; Perkins ND; L Wilson C
FEBS J; 2016 May; 283(10):1812-22. PubMed ID: 26663363
[TBL] [Abstract][Full Text] [Related]
40. Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-kappaB1) but expressing p50.
Ishikawa H; Claudio E; Dambach D; Raventós-Suárez C; Ryan C; Bravo R
J Exp Med; 1998 Apr; 187(7):985-96. PubMed ID: 9529315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
